CA2683997A1 — Oral controlled release compositions comprising vitamin d compound and waxy carrier
Assigned to Eirgen Pharma Ltd · Expires 2008-11-06 · 18y expired
What this patent protects
A stable, controlled release formulation for oral dosing of vitamin D com pounds is disclosed. The formulation is prepared by incorporating one or mor e vitamin D compounds into a solid or semi-solid mixture of waxy materials. Oral dosage forms can be prepared by melt-blending th…
USPTO Abstract
A stable, controlled release formulation for oral dosing of vitamin D com pounds is disclosed. The formulation is prepared by incorporating one or mor e vitamin D compounds into a solid or semi-solid mixture of waxy materials. Oral dosage forms can be prepared by melt-blending the components described herein and filling gelatin capsules with the formulation.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.